Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,358 | 24,609 | 33,870 | 35,274 | 23,995 |
| Marketable Securities | 177,822 | 35,166 | 47,142 | 94,806 | 81,486 |
| TOTAL | $298,864 | $62,331 | $83,346 | $133,442 | $108,510 |
| Non-Current Assets | |||||
| PPE Net | 192 | 281 | 373 | 267 | 260 |
| Investments And Advances | 0 | 0 | 0 | 3,246 | 0 |
| Other Non-Current Assets | 1,557 | 913 | 219 | 231 | 243 |
| TOTAL | $1,749 | $1,194 | $592 | $3,744 | $503 |
| Total Assets | $300,613 | $63,525 | $83,938 | $137,186 | $109,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,285 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,508 | 6,178 | 1,439 | 2,232 | 2,375 |
| Accrued Expenses | 11,246 | 10,195 | 13,149 | 11,993 | 6,771 |
| TOTAL | $18,872 | $18,368 | $16,105 | $15,798 | $10,366 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,834 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 1,517 | 1,517 | 1,517 | 1,573 | 1,220 |
| Other Non-Current Liabilities | 102 | 424 | 136 | 310 | 288 |
| TOTAL | $29,553 | $13,557 | $14,786 | $17,069 | $14,508 |
| Total Liabilities | $48,425 | $31,925 | $30,891 | $32,867 | $24,874 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,236 | 30,241 | 25,001 | 24,698 | 18,244 |
| Common Shares | 5 | 3 | 2 | 2 | 2 |
| Retained earnings | -568,628 | -495,470 | -439,423 | -366,111 | -305,293 |
| Other shareholders' equity | -4 | 0 | -25 | -143 | 56 |
| TOTAL | $252,188 | $31,600 | $53,047 | $104,319 | $84,139 |
| Total Liabilities And Equity | $300,613 | $63,525 | $83,938 | $137,186 | $109,013 |